Did you ever wonder where the scientists who work on biology-based, cutting-edge research initiatives get the tools they need to conduct their world-changing research? A lot of it comes from Gregory T. Lucier, a Harvard University-trained MBA, and his team at Life Technologies. Life Technologies is a global biotechnology tools company that is continuously on the forefront of innovations. From molecular medicine, to pioneering biofuels, to improving the way we fight crime, Mr. Lucier and his team are equipped to provide labs around the globe with the tools they need to conduct their research.
Mr. Lucier, CEO of Life Technologies, provides leadership that is pivotal in forging the company’s path into new, innovative, biotechnical areas. Life Technologies’ “child” company, Ion Torrent, is responsible for creating the first commercial, non-light DNA sequencing system, which is “simpler, faster, more cost effective and scalable than any other technology available . . . The company’s goal is to democratize sequencing and make this critical technology available to every lab,” even labs that could not previously afford DNA sequencing systems.
Mr. Lucier, speaker at the upcoming Atlantic Meets the Pacific Conference, serves on the Board of Directors at Synthetic Genomics, Inc., Carefusion Corporation, and served as Chairman of the Board of Trustees of the Sanford Burnham Medical Research Institute. He is one of the highest paid CEOs in the country, listed as #417 the Forbes’ “America’s Highest Paid Chief Executives” list in 2012.
For more information about the upcoming Atlantic Meets the Pacific (TAMTP) Conference (October 7-9, 2012), contact information and list of speakers, please visit the following link: http://www.atlanticmeetspacific.com
To register for the event, please visit: